These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7082548)

  • 61. Pharmacokinetic analysis of intravenously and orally administered quinidine in horses.
    McGuirk SM; Muir WW; Sams RA
    Am J Vet Res; 1981 Jun; 42(6):938-42. PubMed ID: 7283244
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Multiple oral dosing of ketoconazole influences pharmacokinetics of quinidine after intravenous and oral administration in beagle dogs.
    Kuroha M; Shirai Y; Shimoda M
    J Vet Pharmacol Ther; 2004 Oct; 27(5):355-9. PubMed ID: 15500574
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Compared response to chloroquine, fansidar, quinine, and quinidine slow release of infections with Plasmodium falciparum in the Kivu region of Zaire.
    Delacollette C; Cibanguka J; Buregea H; Nkera J
    Acta Leiden; 1987; 55():159-62. PubMed ID: 3321832
    [No Abstract]   [Full Text] [Related]  

  • 64. The influence of rifampin on quinidine and digoxin.
    Bussey HI; Merritt GJ; Hill EG
    Arch Intern Med; 1984 May; 144(5):1021-3. PubMed ID: 6712395
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparative bioavailability study of three sustained release quinidine formulations.
    Mahon WA; Leeder JS; Brill-Edwards MM; Correia J; MacLeod SM
    Clin Pharmacokinet; 1987 Aug; 13(2):118-24. PubMed ID: 3621768
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The in vitro liberation behavior of quinidine from drug forms with prolonged release by various liberation methods].
    Appelt B; Hennig D; Wenzel U
    Pharmazie; 1986 Jan; 41(1):44-6. PubMed ID: 3960948
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Relative bioavailability of a standard and a sustained-release quinidine tablet.
    Gibson DL; Smith GH; Koup JR; Stewart DK
    Clin Pharm; 1982; 1(4):366-8. PubMed ID: 7185532
    [No Abstract]   [Full Text] [Related]  

  • 68. Absolute quinidine bioavailability.
    Ueda CT; Williamson BJ; Dzindzio BS
    Clin Pharmacol Ther; 1976 Sep; 20(3):260-5. PubMed ID: 954347
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effect of quinidine, used as a probe for the involvement of P-glycoprotein, on the intestinal absorption and pharmacodynamics of methadone.
    Kharasch ED; Hoffer C; Whittington D
    Br J Clin Pharmacol; 2004 May; 57(5):600-10. PubMed ID: 15089813
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Quinidine retard in the prevention of arrhythmias].
    Scébat L; Lenègre J
    Schweiz Rundsch Med Prax; 1971 Sep; 60(38):1255-7. PubMed ID: 5094912
    [No Abstract]   [Full Text] [Related]  

  • 71. Effect of diphenoxylate with atropine sulfate on the bioavailability of quinidine sulfate in healthy subjects.
    Ponzillo JJ; Scavone JM; Paone RP; Lewis GP; Rayment CM; Fitzsimmons WE
    Clin Pharm; 1988 Feb; 7(2):139-42. PubMed ID: 3349749
    [No Abstract]   [Full Text] [Related]  

  • 72. Clinical and electrophysiological effects of intravenous quinidine in man.
    Hirschfeld DS; Ueda CT; Rowland M; Scheinman MM
    Br Heart J; 1977 Mar; 39(3):309-16. PubMed ID: 849392
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Steady-state bioavailability of two sustained-release quinidine preparations: quinidine gluconate versus quinidine sulfate.
    Taggart WV; Holyoak W
    Clin Ther; 1983; 5(4):357-64. PubMed ID: 6871920
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Human pharmacokinetic study of a sustained-release preparation of hydroquinidine: single and chronic administration].
    Flouvat B; Delhotal B; Kahn JC; Crouzette J; Dubourg O; Roux A; Fodor F; Bourdarias JP
    Therapie; 1984; 39(4):337-44. PubMed ID: 6484877
    [No Abstract]   [Full Text] [Related]  

  • 75. Studies of plasma quinidine content. III. The value of delayed absorptive coated tablets in oral quinidine therapy.
    SAMPSON JJ; FOREMAN H; SOLOMON BC
    Circulation; 1952 Apr; 5(4):534-8. PubMed ID: 14916470
    [No Abstract]   [Full Text] [Related]  

  • 76. Concentrations of quinidine in blood following oral, parenteral and rectal administration.
    DITLEFSEN EM
    Acta Med Scand; 1953; 146(2):81-92. PubMed ID: 13091715
    [No Abstract]   [Full Text] [Related]  

  • 77. A study of quinidine dosage in infants and children.
    NEWTON G; CRAWFORD EJ
    J Pediatr; 1955 Dec; 47(6):700-15. PubMed ID: 13272152
    [No Abstract]   [Full Text] [Related]  

  • 78. Quinidine concentrations in serum following two different types of delayed-absorption tablets.
    Ditlefsen EM; Löken HF
    Acta Med Scand; 1966 Mar; 179(3):333-6. PubMed ID: 5910852
    [No Abstract]   [Full Text] [Related]  

  • 79. Concentrations of quinidine in blood following delayed-absorption tablets.
    DITLEFSEN EM
    Acta Med Scand; 1954; 149(1):49-53. PubMed ID: 13171031
    [No Abstract]   [Full Text] [Related]  

  • 80. On the dose dependency of cyclosporin A absorption and disposition in healthy volunteers.
    Reymond JP; Steimer JL; Niederberger W
    J Pharmacokinet Biopharm; 1988 Aug; 16(4):331-53. PubMed ID: 3193363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.